Day One Biopharmaceuticals Inc (NASDAQ: DAWN) open the trading on Thursday, with great promise as it jumped 1.82% to $12.90, before settling in for the
On Tuesday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) was -1.86% drop from the session before settling in for the closing price of $13.47. A 52-week
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) open the trading on Wednesday, with great promise as it jumped 1.55% to $13.80, before settling in for the
On Monday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) opened lower -2.19% from the last session, before settling in for the closing price of $13.72. Price
On Friday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) was -7.05% drop from the session before settling in for the closing price of $14.32. A 52-week
Witnessing the stock’s movement on the chart, on Wednesday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) had a quiet start as it plunged -5.05% to $14.85,
On Friday, Day One Biopharmaceuticals Inc (NASDAQ: DAWN) opened higher 4.00% from the last session, before settling in for the closing price of $15.76. Price
A new trading day began on Tuesday, with Day One Biopharmaceuticals Inc (NASDAQ: DAWN) stock price up 2.30% from the previous day of trading, before
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) open the trading on Wednesday, with great promise as it jumped 0.84% to $14.47, before settling in for the
Day One Biopharmaceuticals Inc (NASDAQ: DAWN) established initial surge of 0.47% at $15.08, before settling in for the price of $15.01 at the close. Taking
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
